TLR7 and neoplasm: Liposomes formulated by loading imiquimod R837, an immune adjuvant TLR7 agonist, and hematoporphyrin monomethyl ether, a sonosensitizer, showed promising tumor growth arrest and was also helpful in preventing metastasis to the lung [153].